--- title: "Carpenter Tan Holdings First Half 2025 Earnings: EPS: CN¥0.44 (vs CN¥0.39 in 1H 2024)" type: "News" locale: "en" url: "https://longbridge.com/en/news/258594606.md" description: "Carpenter Tan Holdings (HKG:837) reported its First Half 2025 earnings, showing an EPS of CN¥0.44, up from CN¥0.39 in 1H 2024. Revenue increased by 9.4% to CN¥287.9m, with net income rising 13% to CN¥109.0m. The profit margin improved to 38% from 37% in the previous year, attributed to higher revenue. Additionally, Carpenter Tan Holdings shares have risen 7.3% over the past week, although there is one warning sign noted in the risk analysis." datetime: "2025-09-23T22:55:40.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/258594606.md) - [en](https://longbridge.com/en/news/258594606.md) - [zh-HK](https://longbridge.com/zh-HK/news/258594606.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/258594606.md) | [繁體中文](https://longbridge.com/zh-HK/news/258594606.md) # Carpenter Tan Holdings First Half 2025 Earnings: EPS: CN¥0.44 (vs CN¥0.39 in 1H 2024) ## Carpenter Tan Holdings (HKG:837) First Half 2025 Results ### Key Financial Results - Revenue: CN¥287.9m (up 9.4% from 1H 2024). - Net income: CN¥109.0m (up 13% from 1H 2024). - Profit margin: 38% (up from 37% in 1H 2024). The increase in margin was driven by higher revenue. - EPS: CN¥0.44 (up from CN¥0.39 in 1H 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. SEHK:837 Earnings and Revenue History September 23rd 2025 _All figures shown in the chart above are for the trailing 12 month (TTM) period_ Carpenter Tan Holdings shares are up 7.3% from a week ago. ### Risk Analysis You should learn about the **1 warning sign** we've spotted with Carpenter Tan Holdings. ### Related Stocks - [CARPENTER TAN (00837.HK)](https://longbridge.com/en/quote/00837.HK.md) ## Related News & Research - [Fed's Logan says so far private credit risks are contained](https://longbridge.com/en/news/281546734.md) - [CSPC Pharmaceutical, Alphamab Oncology's Breast Cancer Drug Study Meets Primary Endpoint](https://longbridge.com/en/news/281325910.md) - [Rep. Hill blames the Senate for failing to pass bank relief](https://longbridge.com/en/news/281384678.md) - [‘Affordability’ will be ‘growing challenge’ for Republicans in midterms: Marc Short](https://longbridge.com/en/news/281232611.md) - [Taking strict action for violation of MCC, poll rules: Kerala CEO](https://longbridge.com/en/news/281672954.md)